| Literature DB >> 19287391 |
David J Loane1, Ana Pocivavsek, Charbel E-H Moussa, Rachel Thompson, Yasuji Matsuoka, Alan I Faden, G William Rebeck, Mark P Burns.
Abstract
Amyloid-beta (Abeta) peptides, found in Alzheimer's disease brain, accumulate rapidly after traumatic brain injury (TBI) in both humans and animals. Here we show that blocking either beta- or gamma-secretase, enzymes required for production of Abeta from amyloid precursor protein (APP), can ameliorate motor and cognitive deficits and reduce cell loss after experimental TBI in mice. Thus, APP secretases are promising targets for treatment of TBI.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19287391 PMCID: PMC2844765 DOI: 10.1038/nm.1940
Source DB: PubMed Journal: Nat Med ISSN: 1078-8956 Impact factor: 53.440